XWELL (XWEL) 10-Q 9 Nov 15 2015 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Nov. 09, 2015
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q3
Entity Registrant Name	Vringo Inc
Entity Central Index Key	1,410,428
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Trading Symbol	VRNG
Entity Common Stock, Shares Outstanding		112,720,838

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Current assets
Cash and cash equivalents	$ 14,402	$ 16,023
Deposits with courts	1,970	2,067
Other current assets	976	510
Total current assets	17,348	18,600
Intangible assets, net	15,189	17,625
Other assets	1,093	1,210
Total assets	33,630	37,435
Current liabilities
Accounts payable and accrued expenses	9,943	4,732
Senior secured convertible notes, net	4,086	0
Conversion feature	75	0
Total current liabilities	14,104	4,732
Long-term liabilities
Derivative warrant liabilities	1,475	174
Other liabilities	$ 1,349	$ 1,349
Commitments and contingencies (Note 10)
Stockholders’ equity
Series A Convertible Preferred stock, $0.01 par value per share; 5,000,000 shares authorized; none issued and outstanding	$ 0	$ 0
Common stock, $0.01 par value per share; 150,000,000 shares authorized; 110,627,065 and 93,404,895 issued and outstanding as of September 30, 2015 and December 31, 2014, respectively	1,106	934
Additional paid-in capital	228,657	215,951
Accumulated deficit	(213,061)	(185,705)
Total stockholders’ equity	16,702	31,180
Total liabilities and stockholders’ equity	$ 33,630	$ 37,435

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2015	Dec. 31, 2014
Common stock, par value	$ 0.01	$ 0.01
Common stock, authorized	150,000,000	150,000,000
Common stock, issued	110,627,065	93,404,895
Common stock, outstanding	110,627,065	93,404,895
Series A convertible preferred stock [Member]
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized	5,000,000	5,000,000
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Revenue	$ 0	$ 150	$ 150	$ 1,200
Costs and Expenses*
Operating legal costs	6,776	8,865	15,341	19,722
Amortization and impairment of intangibles	819	2,333	2,436	4,258
General and administrative	2,095	4,148	7,391	12,594
Total operating expenses	9,690	15,346	25,168	36,574
Operating loss from continuing operations	(9,690)	(15,196)	(25,018)	(35,374)
Non-operating income (expense), net	(145)	35	(322)	57
Gain on revaluation of warrants and conversion feature	716	2,785	1,411	2,057
Interest expense	(1,708)	0	(2,173)	0
Extinguishment of debt	(1,044)	0	(1,254)	0
Issuance of warrants	0	0	0	(65)
Loss from continuing operations before income taxes	(11,871)	(12,376)	(27,356)	(33,325)
Income tax expense	0	0	0	0
Loss from continuing operations	(11,871)	(12,376)	(27,356)	(33,325)
Loss from discontinued operations before income taxes*	0	0	0	(209)
Income tax expense	0	0	0	0
Loss from discontinued operations	0	0	0	(209)
Net loss	$ (11,871)	$ (12,376)	$ (27,356)	$ (33,534)
Basic
Loss per share from continuing operations	$ (0.12)	$ (0.13)	$ (0.28)	$ (0.38)
Loss per share from discontinued operations	0	0	0	0
Total net loss per share	(0.12)	(0.13)	(0.28)	(0.38)
Diluted
Loss per share from continuing operations	(0.12)	(0.16)	(0.28)	(0.4)
Loss per share from discontinued operations	0	0	0	0
Total net loss per share	$ (0.12)	$ (0.16)	$ (0.28)	$ (0.4)
Weighted-average number of shares outstanding during the period:
Basic	102,466,238	92,624,983	96,887,444	88,463,526
Diluted	102,466,238	92,645,299	96,887,444	89,514,852
* Includes stock-based compensation expense, as follows:
Stock Based Compensation Expense	$ 1,066	$ 2,745	$ 4,191	$ 8,563
Operating legal costs [Member]
* Includes stock-based compensation expense, as follows:
Stock Based Compensation Expense	130	307	631	1,035
General and Administrative [Member]
* Includes stock-based compensation expense, as follows:
Stock Based Compensation Expense	936	2,438	3,560	7,377
Discontinued Operations [Member]
* Includes stock-based compensation expense, as follows:
Stock Based Compensation Expense	$ 0	$ 0	$ 0	$ 151

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Balance at Dec. 31, 2013	$ 114,282	$ 845	$ 189,465	$ (76,028)
Exercise of stock options and vesting of RSUs	2,160	18	2,142	0
Issuance of warrants	65	0	65	0
Exercise of warrants	12,999	64	12,935	0
Issuance of common stock for services	384	4	380	0
Stock-based compensation	8,563	0	8,563	0
Net loss for the period	(33,534)	0	0	(33,534)
Balance at Sep. 30, 2014	104,919	931	213,550	(109,562)
Balance at Dec. 31, 2014	31,180	934	215,951	(185,705)
Exercise of stock options and vesting of RSUs	0	3	(3)	0
Reclassification of derivative Reload Warrants and Series 1 Warrants to equity warrants	175	0	175	0
Issuance of common stock for repayment of debt and interest	8,512	169	8,343	0
Stock-based compensation	4,191	0	4,191	0
Net loss for the period	(27,356)	0	0	(27,356)
Balance at Sep. 30, 2015	$ 16,702	$ 1,106	$ 228,657	$ (213,061)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities
Net loss	$ (27,356)	$ (33,534)
Items not affecting cash flows
Depreciation, amortization and impairment of intangibles	2,657	4,495
Amortization of debt discount	1,725	0
Amortization of deferred issuance costs	114	0
Stock-based compensation	4,191	8,563
Issuance of warrants	0	65
Extinguishment of debt	1,254	0
Interest payments	155	0
Change in fair value of warrants and conversion feature	(1,411)	(2,057)
Exchange rate loss (gain)	361	(3)
Changes in current assets and liabilities
Increase in other current assets	(466)	(442)
Increase in payables and accruals	5,223	2,698
Net cash used in operating activities	(13,553)	(20,215)
Cash flows from investing activities
Acquisition of property and equipment	0	(246)
Increase in deposits	(272)	(2,304)
Net cash used in investing activities	(272)	(2,550)
Cash flows from financing activities
Exercise of stock options	0	2,160
Exercise of warrants	0	11,292
Net proceeds from senior secured convertible notes and warrants	12,425	0
Debt issuance costs	(218)	0
Net cash provided by financing activities	12,207	13,452
Effect of exchange rate changes on cash and cash equivalents	(3)	17
Decrease in cash and cash equivalents	(1,621)	(9,296)
Cash and cash equivalents at beginning of period	16,023	33,586
Cash and cash equivalents at end of period	14,402	24,290
Non-cash investing and financing transactions
Non-cash acquisition of cost method investment	0	787
Conversion of derivative warrants into common stock	0	1,707
Issuance of common stock to repay $7,103 of debt and interest	8,512	0
Change in classification of derivative warrants to equity warrants	175	0
Debt discount	$ 2,961	$ 0

General

General	9 Months Ended
	Sep. 30, 2015
General [Abstract]
General	Overview Vringo, Inc., together with its consolidated subsidiaries (“Vringo” or the “Company”), is engaged in the development and monetization of intellectual property worldwide. The Company's intellectual property portfolio consists of over 600 patents and patent applications covering telecom infrastructure, internet search and mobile technologies. The Company’s patents and patent applications have been developed internally or acquired from third parties. On October 15, 2015, the Company completed the acquisition of International Development Group Limited, a Maryland corporation (“IDG”). Pursuant to the Stock Purchase Agreement (the “Purchase Agreement”), the Company acquired 100% of the capital stock of IDG, including two of IDG’s subsidiaries, fliCharge International Ltd. (“fliCharge”), in which IDG owns 70% of the capital stock and controls the operations, and the wholly-owned Group Mobile International Ltd. (“Group Mobile”). fliCharge owns patented conductive wire-free charging technology and is focused on innovation, sales, manufacturing and licensing core technology to large corporations in various industries. Group Mobile is a company with full service technical and customer support in rugged computers, mobile devices and accessories. The Company expanded their intellectual property and technology portfolio with this acquisition. See Note 12 for further detail on the acquisition of IDG. Prior to December 31, 2013, the Company operated a global platform for the distribution of mobile social applications and the services that it developed. On February 18, 2014, the Company executed the sale of its mobile social application business to InfoMedia Services Limited (“InfoMedia”), receiving an 8.25 Infrastructure Patents The Company’s infrastructure patents are primarily made up of a patent portfolio purchased from Nokia Corporation (“Nokia”) in 2012. This patent portfolio is comprised of 124 patent families with counterparts in certain jurisdictions worldwide and encompass technologies relating to telecom infrastructure, including communication management, data and signal transmission, mobility management, radio resources management and services. Declarations were filed by Nokia indicating that 31 of the 124 patent families acquired may be essential to wireless communications standards. The Company also owns other acquired infrastructure patent portfolios and has filed over 60 internally developed patent applications. As one of the means of realizing the value of the patents on telecom infrastructure, the Company has filed a number of suits against ZTE Corporation (“ZTE”), ASUSTeK Computer Inc. (“ASUS”), and certain of their subsidiaries, affiliates and other companies in the United States (“U.S.”), European jurisdictions, India, Australia, Brazil, and Malaysia alleging infringement of certain U.S., European, Indian, Australian, Brazilian, and Malaysian patents. In response, ZTE Corporation or its affiliates have filed a number of counterclaims and other responsive cases in various countries such as the U.S., certain European jurisdictions, the People’s Republic of China (“China”) and To date, in connection with the suits filed against ZTE, Vringo’s patents have been found to be infringed in the United Kingdom (“UK”) and Germany, and preliminary relief has been granted in India, Brazil, Romania, and the Netherlands. Separately, Vringo has entered into settlement and license agreements with ADT, Tyco, D-Link, Belkin, Hop On, Inc., and two other parties. Vringo continues to license its home monitoring portfolio. Quantum Stream In 2012, the Company purchased a portfolio of patents invented by Tayo Akadiri relating to content distribution. The portfolio includes seven patents as well as several pending patent applications. As one of the means of realizing the value of these patents, on October 20, 2015, the Company filed suit against DirecTV in the United States District Court for the Southern District of New York. fliCharge Founded in 2014, fliCharge owns a patented, conductive, wire-free charging technology that is already on the market and available to consumers. The patented fliCharge technology consists of a wire-free charging solution that can simultaneously charge multiple battery operated devices on the same charging pad regardless of their power requirement or position on the pad; users simply place their enabled device onto a fliCharge pad. Group Mobile Founded in 2002, Group Mobile is a supplier of built-to-order rugged computers, mobile devices and accessories. Group Mobile provides a high touch sales experience with full service technical and customer support in the rugged mobile computer market. Group Mobile’s customers include large corporations, military suppliers, small businesses and individuals. Rugged products sold by Group Mobile can be found in military helicopters, police cruisers and ambulance fleets as well as on construction sites, oil rigs and manufacturing facilities. Vringo intends to expand this business through expanding available product lines and further augmenting sales and marketing. Search Patents On September 15, 2011, the Company’s wholly-owned subsidiary, I/P Engine, Inc. (“I/P Engine”), initiated litigation against AOL Inc., Google, Inc., IAC Search & Media, Inc., Gannett Company, Inc., and Target Corporation (collectively, the “Defendants”) for infringement of claims of certain of its owned patents. Trial commenced during 2012, and, on November 6, 2012, the jury ruled in favor of I/P Engine and against the Defendants. On August 15, 2014, the Court of Appeals for the Federal Circuit (“Federal Circuit”) held that the claims of the patents-in-suit asserted by I/P Engine against the Defendants are invalid for obviousness. The Company sought review by the Supreme Court of the United States (“Supreme Court”) of the Federal Circuit’s opinion, and, on October 5, 2015, the Supreme Court denied Vringo’s petition for a writ of certiorari. Financial condition As of September 30, 2015, the Company had a cash balance of $ 14,402 1,500 2,200 1,970 16,702 31,180 On May 4, 2015 (the “Closing Date”), the Company entered into a securities purchase agreement with certain institutional investors in a registered direct offering of $ 12,500 1.00 8 21 5,375,000 1.00 12,425 The principal amount of the outstanding Notes is being repaid monthly, and the Company may make such payments and related interest payments in cash or, subject to certain conditions, in registered shares of the Company’s common stock, at its election. If the Company chooses to repay the Notes in shares of its common stock, the shares are issued at a 15 During August 2015, the holders of the Notes accelerated six principal installments in exchange for common stock as permitted under the securities purchase agreement. The debt is now expected to mature in July 2016 The Company’s operating plans include efforts to increase revenue through the licensing of its intellectual property, strategic partnerships, and litigation, when required, which may be resolved through a settlement or collection, and generation of revenue from sales of wire-free charging stations, rugged computers and mobile devices. Disputes regarding the assertion of patents and other intellectual property rights are highly complex and technical. The majority of the Company’s expenditures consist of costs related to the Company’s litigation campaigns. In the cases against ZTE and ASUS, the Company incurred costs during the nine month period ended September 30, 2015 related to the preparation and filing of briefs and other court documents, as well as case preparation and management. A large percentage of these costs were incurred in the UK and the U.S. In civil law jurisdictions, such as Germany, France, Spain, and others, the majority of costs are incurred in the early stages of litigation. With respect to the Company’s litigation in such countries, the respective campaigns are currently in the later stages and therefore the Company has already incurred the large majority of the related anticipated costs. As such, based on the Company’s plans, costs in these jurisdictions are projected to be lower in the remainder of 2015 and other future periods. Despite the Company’s plans, its legal proceedings may continue for several years and may require significant expenditures for legal fees and other expenses. Further, should the Company be deemed the losing party in certain of its litigations, it may be liable for some or all of its opponents’ legal fees. In addition, in connection with litigation, the Company has made several affirmative financial guarantees to courts around the world, and might face the need to make additional guarantees in the future. In addition, the Company’s plans to continue to expand its planned operations through acquisitions may be time consuming, complex and costly to consummate. The Company may utilize many different transaction structures in its acquisitions and the terms of such acquisition agreements tend to be heavily negotiated. The Company’s future ability to raise capital, if necessary, may be limited. Even if the Company is able to acquire other businesses, there is no guarantee that it will generate sufficient revenue related to those assets to offset the acquisition costs. Therefore, no assurance can be given at this time as to whether the Company will be able to achieve its objectives or whether it will have the sources of liquidity for follow through with its operating plans. In addition, until the Company generates sufficient revenue, the Company may need to raise additional funds, which may be achieved through the issuance of additional equity or debt, or through loans from financial institutions. There can be no assurance, however, that any such opportunities will materialize. The Company may also be able to raise additional funds through the exercise of its outstanding warrants and options, however, substantially all of such outstanding equity instruments are currently “out of the money.” As a result of the events and circumstances described above, including the cash proceeds received in connection with the May 2015 financing transaction and the Company’s operating plans, which include paying the principal and interest related to the Notes in shares of the Company’s common stock, the Company believes that it currently has sufficient cash to continue its current operations for at least the next twelve months.

Accounting and Reporting Polici

Accounting and Reporting Policies	9 Months Ended
	Sep. 30, 2015
Accounting Policies [Abstract]
Accounting and Reporting Policies	Note 2. Accounting and Reporting Policies The accompanying interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information and the instructions to Rule 10-01 of Regulation S-X, and should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2014. All adjustments that, in the opinion of management, are necessary for a fair presentation for the periods presented have been reflected by the Company. Such adjustments are of a normal, recurring nature. The results of operations for the three month and nine month periods ended September 30, 2015 are not necessarily indicative of the results that may be expected for the entire fiscal year or for any other interim period. All significant intercompany balances and transactions have been eliminated in consolidation. The preparation of accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from such estimates. Significant items subject to such estimates and assumptions include the Company’s intangibles assets, the useful lives of the Company’s intangible assets, the valuation of the Company’s derivative warrants, the valuation of stock-based compensation, deferred tax assets and liabilities, income tax uncertainties, and other contingencies. The Company conducts certain transactions in foreign currencies, which are recorded at the exchange rate as of the transaction date. All exchange gains and losses occurring from the remeasurement of monetary balance sheet items denominated in non-U.S. dollar currencies are reflected as non-operating income or expense in the consolidated statements of operations. The Company invests its cash in money market funds with financial institutions. The Company has established guidelines relating to diversification and maturities of its investments in order to minimize credit risk and maintain high liquidity of funds. All highly liquid investments with original maturities of three months or less at acquisition date are considered cash equivalents. The Company recognizes all derivative instruments as either assets or liabilities in the consolidated balance sheets at their respective fair values. The Company's derivative instruments have been recorded as liabilities at fair value, and are revalued at each reporting date, with changes in the fair value of the instruments included in the consolidated statements of operations as non-operating income (expense). The Company reviews the terms of features embedded in non-derivative instruments to determine if such features require bifurcation and separate accounting as derivative financial instruments. Equity-linked derivative instruments are evaluated in accordance with FASB Accounting Standard Codification 815-40, Contracts in an Entity’s Own Equity Intangible assets include purchased patents which are recorded based on the cost to acquire them. These assets are amortized over their remaining estimated useful lives, which are periodically evaluated for reasonableness. The Company’s intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In assessing the recoverability of the Company's intangible assets, the Company must make estimates and assumptions regarding future cash flows and other factors to determine the fair value of the respective assets. These estimates and assumptions could have a significant impact on whether an impairment charge is recognized and also the magnitude of any such charge. Fair value estimates are made at a specific point in time, based on relevant information. These estimates are subjective in nature and involve uncertainties and matters of significant judgments and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates. If these estimates or material related assumptions change in the future, the Company may be required to record impairment charges related to its intangible assets. Revenue from patent licensing and enforcement is recognized if collectability is reasonably assured, persuasive evidence of an arrangement exists, the sales price is fixed or determinable and delivery of the service has been rendered. The Company uses management's best estimate of selling price for individual elements in multiple-element arrangements, where vendor specific evidence or third party evidence of selling price is not available. Currently, the Company’s revenue arrangements provide for the payment of contractually determined fees and other consideration for the grant of certain intellectual property rights related to the Company’s patents. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patents, (ii) the release of the licensee from certain claims, and (iii) the dismissal of any pending litigation. The intellectual property rights granted typically extend until the expiration of the related patents. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on the Company’s part to maintain or upgrade the related technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the upfront payment. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, upon receipt of the upfront fee, and when all other revenue recognition criteria have been met. Operating legal costs mainly include expenses incurred in connection with the Company’s patent licensing and enforcement activities, patent-related legal expenses paid to external patent counsel (including contingent legal fees), licensing and enforcement related research, consulting and other expenses paid to third parties, as well as related internal payroll expenses and stock-based compensation. In addition, amounts received by the Company for reimbursements of legal fees in connection with its litigation campaigns are recorded in Operating legal costs as an offset to legal expense. Stock-based compensation is recognized as an expense in the consolidated statements of operations and such cost is measured at the grant-date fair value of the equity-settled award. The fair value of stock options is estimated at the date of grant using the Black-Scholes-Merton option-pricing model. The expense is recognized on a straight-line basis, over the requisite service period. The Company uses the simplified method to estimate the expected term of options due to insufficient history and high turnover in the past. Since the Company lacks sufficient history, expected volatility is estimated based on a weighted average historical volatility of the Company and comparable entities with publicly traded shares. The risk-free rate for the expected term of the option is based on the U.S. Treasury yield curve at the date of grant. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements (Topic 205): Going Concern In November 2014, the FASB issued ASU 2014-16, Derivatives and Hedging: Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share is More Akin to Debt or to Equity In April 2015, the FASB issued ASU No. 2015-03, Simplifying the Presentation of Debt Issuance Costs (k) Reclassification Certain balances have been reclassified to conform to presentation requirements.

Intangible Assets

Intangible Assets	9 Months Ended
	Sep. 30, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Note 3. Intangible Assets September 30, December 31, Weighted average 2015 2014 amortization period (years) Patents $ 28,213 $ 28,213 8.9 Less: accumulated amortization and impairment (13,024) (10,588) $ 15,189 $ 17,625 The Company’s patents consist of three major patent portfolios, which were acquired from third parties, as well as a number of internally developed patents. The costs related to internally developed patents are expensed as incurred. In August 2012, the Company purchased a portfolio from Nokia consisting of various patents and patent applications as described in Note 1. The total consideration paid for the portfolio was $ 22,000 548 35 The Company’s patents are amortized over their expected useful lives (i.e., through the expiration date of the patent). During the three and nine month periods ended September 30, 2015, the Company recorded amortization expense of $ 819 2,436 978 2,903 During the third quarter of 2014, the Company determined that there were impairment indicators related to certain of its patents. A significant factor that was considered when making this determination included the announcement of the Federal Circuit’s decision on August 15, 2014. The Company concluded that this factor was deemed a “triggering” event requiring that the related patent assets be tested for impairment during the third quarter of 2014. In performing this impairment test, the Company determined that the patent portfolio containing the patents-in-suit in I/P Engine's litigation against AOL Inc., Google Inc. et al., which represents an asset group, was subject to impairment testing. In the first step of the impairment test, the Company utilized its projections of future undiscounted cash flows based on the Company’s existing plans for the patents. As a result, it was determined that the Company’s projections of future undiscounted cash flows were less than the carrying value of the asset group. Accordingly, the Company performed the second step of the impairment test to measure the potential impairment by calculating the asset group’s fair value. This resulted in an impairment of $ 1,355

Net Loss per Common Share

Net Loss per Common Share	9 Months Ended
	Sep. 30, 2015
Earnings Per Share, Basic and Diluted [Abstract]
Net Loss per Common Share	Note 4. Net Loss per Common Share Basic net loss per share is computed by dividing the net loss for the period by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing the net loss for the period by the weighted-average number of shares of common stock plus dilutive potential common stock considered outstanding during the period. However, as the Company generated net losses in all periods presented, some potentially dilutive securities that relate to the continuing operations, including certain warrants and stock options, were not reflected in diluted net loss per share because the impact of such instruments was anti-dilutive. Three months ended Nine months ended September 30, September 30, 2015 2014 2015 2014 Basic Numerator: Loss from continuing operations attributable to shares of common stock $ (11,871) $ (12,376) $ (27,356) $ (33,325) Loss from discontinued operations attributable to shares of common stock — — $ — $ (209) Net loss attributable to shares of common stock $ (11,871) $ (12,376) $ (27,356) $ (33,534) Basic Denominator: Weighted average number of shares of common stock outstanding during the period 102,466,238 92,624,983 96,887,444 88,463,526 Basic common stock shares outstanding 102,466,238 92,624,983 96,887,444 88,463,526 Basic loss per common stock share from continuing operations $ (0.12) $ (0.13) $ (0.28) $ (0.38) Basic loss per common stock share from discontinued operations (0.00) (0.00) (0.00) (0.00) Basic net loss per common stock share $ (0.12) $ (0.13) $ (0.28) $ (0.38) Diluted Numerator: Net loss from continuing operations attributable to shares of common stock $ (11,871) $ (12,376) $ (27,356) $ (33,325) Increase in net loss attributable to derivative warrants — (2,785) — (2,057) Diluted net loss from continuing operations attributable to shares of common stock (11,871) (15,161) (27,356) (35,382) Diluted net loss from discontinued operations attributable to shares of common stock — — — (209) Diluted net loss attributable to shares of common stock $ (11,871) $ (15,161) $ (27,356) $ (35,591) Diluted Denominator: Basic common stock shares outstanding 102,466,238 92,624,983 96,887,444 88,463,526 Weighted average number of derivative warrants outstanding during the period — 20,316 — 1,051,326 Diluted common stock shares outstanding 102,466,238 92,645,299 96,887,444 89,514,852 Diluted loss per common stock share from continuing operations $ (0.12) $ (0.16) $ (0.28) $ (0.40) Diluted loss per common stock share from discontinued operations (0.00) (0.00) (0.00) (0.00) Diluted net loss per common stock share $ (0.12) $ (0.16) $ (0.28) $ (0.40) Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact: Both vested and unvested options to purchase an equal number of shares of common stock of the Company 8,714,845 10,089,595 8,714,845 10,089,595 Unvested RSUs to issue an equal number of shares of common stock of the Company 543,231 1,425,872 543,231 1,425,872 Warrants to purchase an equal number of shares of common stock of the Company 9,566,796 17,388,161 9,566,796 16,147,560 Conversion feature of Senior Secured Notes 11,309,524 — 12,500,000 — Total number of potentially dilutive instruments, excluded from the calculation of net loss per share 30,134,396 28,903,628 31,324,872 27,663,027

Discontinued Operations

Discontinued Operations	9 Months Ended
	Sep. 30, 2015
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations and Assets Held For Sale	Note 5. Discontinued Operations On February 18, 2014, the Company executed the sale of its mobile social application business to InfoMedia. As consideration for the assets and agreements related to the Company’s mobile social application business, the Company received 18 Class B shares of InfoMedia, which represent an 8.25 787 In connection with the sale of its mobile social application business, the Company is required to present the results of the Company’s mobile social application business as discontinued operations in the consolidated statements of operations. Revenue $ 37 Operating expenses (266) Operating loss (229) Non-operating income 20 Loss before taxes on income (209) Income tax expense - Loss from discontinued operations $ (209)

Senior Secured Convertible Note

Senior Secured Convertible Notes	9 Months Ended
	Sep. 30, 2015
Debt Disclosure [Abstract]
Senior Secured Convertible Notes	On May 4, 2015 (the “Closing Date”), the Company entered into a securities purchase agreement with certain institutional investors in a registered direct offering of $ 12,500 1.00 8 21 5,375,000 1.00 12,425 218 The principal amount of the outstanding Notes is being repaid monthly, and the Company may make such payments and related interest payments in cash or, subject to certain conditions, in registered shares of the Company’s common stock, at its election. On each of the principal installment dates, the Company’s scheduled principal amortization payment is an amount equal to $ 595 15 The 8% interest is paid quarterly, beginning July 1, 2015, and the Company may make such payments in cash or registered shares of the Company’s common stock, at its election. If the Company chooses to repay the Notes in shares of its common stock, the shares for the payment of interest are issued at the then-current market price of the Company’s common stock. Net cash proceeds from the Notes ($12,500 less investors issuance costs of $75) $ 12,425 Debt discount: May 2015 Warrants 1,717 Conversion feature 1,244 Total Debt discount attributed to Warrants and Conversion feature 2,961 Net Total – May 4, 2015 9,464 Q2 Debt discount amortization 289 Q2 Debt repayments (1,191) Net Total – June 30, 2015 8,562 Q3 Debt discount amortization 1,436 Q3 Debt repayments (5,912) Net Total – September 30, 2015 (presented as short-term) $ 4,086 The debt discount is attributable to the value of the separately accounted for conversion feature and May 2015 Warrants issued in connection with the financing. The embedded conversion feature derivatives relate to the conversion option, redemption in case of an event of default, and redemption in the case of a change in control features of the Notes. The embedded derivatives were evaluated under ASC topic 815-15, were bifurcated from the debt host, and were classified as liabilities in the consolidated balance sheet. The debt discount is amortized using the effective interest method over the term of the Notes. For the three and nine months ended September 30, 2015, the Company recorded $ 1,436 1,725 93 114 179 During August 2015, the holders of the Notes accelerated six principal installments in exchange for common stock as permitted under the securities purchase agreement. The debt is now expected to mature in July 2016. During the three and nine months ended September 30, 2015, the Company made principal payments in the aggregate amount of $ 5,912 7,103 14.6 16.9 1,044 1,254 See Note 7 and 8 for further detail on the fair value of the May 2015 Warrants and conversion feature.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2015
Fair Value Measurements [Abstract]
Fair Value Measurements	Note 7. Fair Value Measurements The Company measures fair value in accordance with FASB Accounting Standard Codification (“ASC”) 820-10, Fair Value Measurements and Disclosures Level 1 : Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. Level 2 : Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. Level 3 : Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Fair value measurement at reporting date using Quoted prices in active markets Significant other Significant for identical observable unobservable Balance assets (Level 1) inputs (Level 2) inputs (Level 3) September 30, 2015: May 2015 Warrants $ 1,475 $ — $ — $ 1,475 Conversion feature $ 75 $ — $ — $ 75 December 31, 2014: Conversion Warrants, the derivative Reload Warrants and the derivative Series 1 Warrants $ 175 $ — $ — $ 175 The Company measures its derivative liabilities at fair value. The Conversion Warrants, the derivative Reload Warrants and the derivative Series 1 Warrants were classified within Level 3 because they were valued using the Black-Scholes-Merton and the Monte-Carlo models, as these warrants included down-round protection clauses, which utilize significant inputs that are unobservable in the market. On January 1, 2015, the down-round protection clauses associated with all of the Company’s outstanding derivative warrants expired and, as a result, these warrants no longer meet the criteria for liability classification. As such, the related liabilities were revalued as of January 1, 2015 and the balance of $ 175 174 1 The May 2015 Warrants were classified within Level 3 because they were valued using the Black-Sholes-Merton model, which utilizes significant inputs that are unobservable in the market. They are recorded as derivative liability warrants as they are freestanding instruments and there are several features within the warrants that may require the Company to cash settle or partially cash settle. In particular, the Company may have to cash settle, partially cash settle, or make cash payments to the holders including cash settlement upon exercise when insufficient shares are authorized to be issued, and that the Company is obligated to issue registered shares when the warrants are exercised. The derivative liability is initially measured at fair value and marked to market at each balance sheet date. The conversion feature was classified within Level 3 because it was valued using the Monte-Carlo model, which utilizes significant inputs that are unobservable in the market. The embedded conversion feature derivatives relate to the conversion option, redemption in case of an event of default, and redemption in the case of a change in control features of the Notes. The conversion feature was separated from the host debt contract and accounted for as a derivative instrument because the feature is not clearly and closely related to the debt host and a separate instrument with the same terms as the embedded derivative would be a derivative instrument. In addition to the above, the Company’s financial instruments as of September 30, 2015 and December 31, 2014 consisted of cash, cash equivalents, receivables, accounts payable and deposits. The carrying amounts of all the aforementioned financial instruments approximate fair value because of the short-term maturities of these instruments. Conversion Warrants, the derivative Reload Warrants and the derivative May 2015 Conversion Series 1 Warrants Warrants feature December 31, 2014 $ 175 $ — $ — Reclassification of derivative Reload Warrants and Series 1 Warrants to equity warrants (175) — — Issuance of Notes and derivative warrants on May 4, 2015 — 1,717 1,244 Gain on revaluation of warrants and conversion feature — (242) (1,169) September 30, 2015 — 1,475 75 During August 2015, the holders of the Notes accelerated six principal installments in exchange for common stock as permitted under the securities purchase agreement. The debt is now expected to mature in July 2016. These events resulted in a significant decline in the value of the conversion feature between May 4, 2015 and September 30, 2015, which resulted in a concurrent gain on the revaluation of the conversion feature. Valuation processes for Level 3 Fair Value Measurements December 31, 2014: Unobservable Description Valuation technique inputs Range Conversion Warrants, derivative Reload Warrants and derivative Series 1 Warrants Black-Scholes-Merton and the Monte-Carlo models Volatility 56.55 77.06 Risk free interest rate 0.13 0.87 Expected term, in years 0.48 2.55 Dividend yield 0 September 30, 2015: Unobservable Description Valuation technique inputs Range Conversion feature Monte-Carlo model Volatility 65.82 Risk free interest rate 0.13 Expected term, in years 0.76 Conversion price $ 1.00 May 2015 Warrants Black-Scholes-Merton Volatility 78.18 Risk free interest rate 1.30 Expected term, in years 4.59 Dividend yield 0.00 Sensitivity of Level 3 measurements to changes in significant unobservable inputs The inputs to estimate the fair value of the Company’s derivative warrant liabilities and conversion feature were the current market price of the Company’s common stock, the exercise price of the warrants and conversion feature, their remaining expected term, the volatility of the Company’s common stock price and the risk-free interest rate over the expected term. Significant changes in any of those inputs in isolation can result in a significant change in the fair value measurement. Generally, an increase in the market price of the Company’s shares of common stock, an increase in the volatility of the Company’s shares of common stock, and an increase in the remaining term of the warrants and conversion feature would each result in a directionally similar change in the estimated fair value of the Company’s warrants. Such changes would increase the associated liability while decreases in these assumptions would decrease the associated liability. An increase in the risk-free interest rate or a decrease in the differential between the warrants’ and conversion feature’s exercise prices and the market price of the Company’s shares of common stock would result in a decrease in the estimated fair value measurement and thus a decrease in the associated liability. The Company has not, and does not plan to, declare dividends on its common stock, and as such, there is no change in the estimated fair value of the warrants and conversion feature due to the dividend assumption.

Warrants

Warrants	9 Months Ended
	Sep. 30, 2015
Warrants and Rights Note Disclosure [Abstract]
Warrants	Note 8. Warrants Weighted average Exercise No. of warrants exercise price price range December 31, 2014 17,402,654 $ 4.26 $0.94 - $5.06 Granted 5,375,000 $ 1.00 $1.00 Exercised — — — Expired (13,210,858) $ 5.06 $0.94 - $5.06 September 30, 2015 9,566,796 $ 1.33 $1.00 - $1.76 On May 4, 2015, the Company issued warrants to purchase up to 5,375,000 1.00 Prior to June 21, 2015, the Company had public warrants to purchase 4,784,000 5.06 8,426,858 Certain of the Company’s outstanding warrants are classified as equity warrants and certain are classified as derivative liability. Remaining No. outstanding Exercise price contractual life Expiration Date Series 1 Warrants 1,490,250 $ 1.76 1.80 years July 19, 2017 Series 2 Warrants 1,943,523 $ 1.76 1.80 years July 19, 2017 Reload Warrants 758,023 $ 1.76 1.36 years February 6, 2017 Outstanding as of September 30, 2015 4,191,796 The Company’s outstanding derivative liability warrants as of September 30, 2015 consist of the following: Remaining No. outstanding Exercise price contractual life Expiration Date May 2015 Warrants 5,375,000 $ 1.00 4.59 years May 4, 2020

Stock-based Compensation

Stock-based Compensation	9 Months Ended
	Sep. 30, 2015
Share-based Compensation [Abstract]
Stock-based Compensation	Note 9. Stock-based Compensation The Company has a stock-based compensation plan available to grant stock options and RSUs to the Company’s directors, employees and consultants. Under the 2012 Employee, Director and Consultant Equity Incentive Plan (the “Plan”), a maximum of 15,600,000 5,462,066 No. of Fair market value Assumptions used in Black-Scholes Title Grant date options Exercise price at grant date Vesting terms Option pricing model Directors and employees January 2015 1,150,000 $0.51 - $0.59 $0.33 - $0.38 Over 1 year for Directors; Over 3 years for Volatility: 74.9 % - 77.1 Employees Risk free interest rate: 1.27 1.51 Expected term, in years: 5.31 5.81 Dividend yield: 0.00 Certain options granted are subject to acceleration of vesting of 75 100 RSUs Options Weighted average Weighted average Weighted average No. of RSUs grant date fair value No. of options exercise price Exercise price range grant date fair value Outstanding at December 31, 2014 1,196,357 $ 3.64 8,052,345 $ 3.36 $0.96 - $5.50 $ 2.24 Granted — — 1,150,000 $ 0.54 $0.51 - $0.59 $ 0.35 Vested/Exercised (299,480) $ 3.65 — — — — Forfeited (353,646) $ 3.63 (487,500) $ 1.94 $0.51 - $3.76 $ 1.11 Expired — — — — — — Outstanding at September 30, 2015 543,231 $ 3.63 8,714,845 $ 3.07 $0.51 - $5.50 $ 2.05 Exercisable at September 30, 2015 — — 7,787,485 $ 3.20 $0.51 - $5.50 The Company did not recognize tax benefits related to its stock-based compensation as there is a full valuation allowance recorded.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2015
Commitments and Contingencies [Abstract]
Commitments and Contingencies	Note 10. Commitments and Contingencies The Company retains the services of professional service providers, including law firms that specialize in intellectual property licensing, enforcement and patent law. These service providers are often retained on an hourly, monthly, project, contingent or a blended fee basis. In contingency fee arrangements, a portion of the legal fee is based on predetermined milestones or the Company’s actual collection of funds. The Company accrues contingent fees when it is probable that the milestones will be achieved and the fees can be reasonably estimated. The Company’s subsidiaries have filed patent infringement lawsuits against ZTE and its subsidiaries in the UK United Kingdom Pursuant to negotiation with ZTE’s UK subsidiary, the Company made two written commitments, in November 2012 and May 2013, representing payment should a liability by Vringo Infrastructure arise as a result of the two cases it has filed. Each of the cases filed include three patents which the Company has alleged are infringed by ZTE. The defendants estimated the total possible liability to be no more than approximately $ 2,900 In March 2014, the Company withdrew one of the patents included in the first case against ZTE’s UK subsidiary. ZTE withdrew its invalidity counterclaims. In November 2014, with respect to another patent included in the first case, the Court found that Vringo’s patent is valid as amended and infringed by ZTE. ZTE did not appeal the decision, and the decision is final. On February 17, 2015, Vringo withdrew its infringement claims against ZTE on three of the four remaining European Patents in suit in the second litigation in the UK. ZTE subsequently withdrew its invalidity counterclaims in respect of these three patents. On April 10, 2015, Vringo and ZTE reached an agreement in relation to the remaining European Patent in issue (EP (UK) 1 330 933) in the second patent case in the UK in which the parties will withdraw their respective claims and counterclaims. Germany On September 13, 2013 and January 28, 2014, Vringo Germany filed two suits in the Regional Court of Düsseldorf, alleging infringement of two European patents by ZTE’s German subsidiary. Those cases were heard by the Court on November 27, 2014. On January 22, 2015, the Court issued its judgment, finding that ZTE does not infringe either patent. On February 17, 2015, the Company Netherlands In the Netherlands, on October 23, 2014, ZTE filed suit in the District Court of The Hague seeking the invalidity of Vringo’s European Patent that is the subject of the other proceedings taking place in the same Court. A hearing in this matter took place in the third quarter of 2015. On October 28, 2015, the District Court of The Hague found the European patent invalid. The Company plans to appeal the ruling. The appeal process is anticipated to take up to one year. France On March 29, 2013, Vringo Infrastructure filed a patent infringement lawsuit in France in the Tribunal de Grande Instance de Paris (the “Tribunal”), alleging infringement of the French part of two European patents. Vringo Infrastructure filed the lawsuit based on particular information uncovered during a seizure to obtain evidence of infringement, known as a saisie-contrefaçon, which was executed at two of ZTE's facilities in France. On October 30, 2015, the Tribunal held the claims-in-suit of the first European patent invalid, and held that the claims-in-suit of the second European patent do not implement the relevant standard, without commenting on that patent’s validity. The Company plans to appeal the Tribunal’s ruling. The appeal process is anticipated to take at least one year. People’s Republic of China ZTE has filed 33 reexamination requests of Vringo’s Chinese patents with the Patent Re-Examination Board (“PRB”) of the State Intellectual Property Office of the People’s Republic of China. To date, the PRB has upheld the validity of 17 of the Company’s patents, partially upheld the validity of two of the Company’s patents, and has held that 13 of the Company’s patents are invalid. The Company has filed appeals on the PRB’s decision on the patents that have been held invalid. The appeal process is expected to take at least one year. The remaining reexamination requests remain pending, with decisions expected to be rendered on a rolling basis. On February 21, 2014, ZTE filed a civil complaint against the Company and certain of its subsidiaries in the Shenzhen Intermediate Court alleging that the Company violated China’s antimonopoly laws. The Company received notice of the action on June 26, 2014. The Company intends to vigorously contest all aspects of this action in the appropriate manner. On July 28, 2014, the Company filed a motion to have this complaint dismissed due to lack of jurisdiction. On August 6, 2014, the Court dismissed this motion. The Company filed an appeal of the dismissal, which was denied by the Court. The Court conducted a hearing on May 29, 2015 for the parties to submit any evidence on which they intended to rely. During this hearing, ZTE amended its complaint to increase its damages demand. As a result, the Company filed a motion contesting the jurisdiction of the Court, which was denied. The Company’s appeal of the jurisdictional question is pending. Trial on the merits, which had been scheduled to begin on June 9, 2015, has been postponed pending Vringo’s appeal. The appellate process is expected to take several months. The Company has not made a determination of what the potential liability may be should it lose the case in China. Deposits with courts On May 5, 2014, the Company deposited a bond of € 1,000 1,124 50 56 In Brazil, as a condition of the relief requested, the Company deposited R$ 2,020 492 In Romania, Vringo Infrastructure filed a patent infringement lawsuit against ZTE in the Bucharest Tribunal Civil Section on June 23, 2014 and the Court granted an ex-parte preliminary injunction, ordering ZTE to cease any importation, exportation, introduction on the market, offer for sale, storage, sale, trade, distribution, promotion, or any other business activity regarding the infringing product. The Company deposited a bond of € 243 273 The bond deposits in Germany and Romania and the surety deposit in Brazil are included in Deposits with courts in the consolidated balance sheets as of September 30, 2015 and December 31, 2014. Leases In January 2014, the Company entered into an amended lease agreement for its corporate executive office in New York for the lease of a different office space within the same building. The initial annual rental fee for this new office is approximately $ 403 91 274 91 273

Risks and Uncertainties

Risks and Uncertainties	9 Months Ended
	Sep. 30, 2015
Risks and Uncertainties [Abstract]
Risks and Uncertainties	Note 11. Risks and Uncertainties (a) New legislation, regulations or rulings that impact the patent enforcement process or the rights of patent holders could negatively affect the Company’s current business model. For example, limitations on the ability to bring patent enforcement claims, limitations on potential liability for patent infringement, lower evidentiary standards for invalidating patents, increases in the cost to resolve patent disputes and other similar developments could negatively affect the Company’s ability to assert its patent or other intellectual property rights. (b) The patents owned by the Company are presumed to be valid and enforceable. As part of the Company’s ongoing legal proceedings, the validity and/or enforceability of its patents is often challenged in a court or an administrative proceeding. During the second half of 2014, the Patent Re-Examination Board of the State Intellectual Property Office of the People’s Republic of China held that 13 of the Company's Chinese patents, and partial claims on two of the Company’s other Chinese patents, are invalid. The Company is appealing these decisions. The Company’s other patents have not been declared to be invalid or unenforceable to date. (c) Financial instruments which potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. The Company maintains its cash and cash equivalents with various major financial institutions. These major financial institutions are located in the United States and the Company’s policy is designed to limit exposure to any one institution. (d) A portion of the Company’s expenses are denominated in foreign currencies. If the value of the U.S. dollar weakens against the value of these currencies, there will be a negative impact on the Company’s operating costs. In addition, the Company is subject to the risk of exchange rate fluctuations to the extent it holds monetary assets and liabilities in these currencies. (e) The Notes are repaid on a monthly basis in cash or shares at the Company’s election. If the Company is unable to satisfy certain equity conditions, it will be required to pay all amounts due on any installment date in cash. The Company’s ability to timely repay the Notes, to redeem the Notes, and to fund working capital needs and planned capital expenditures depends on its ability to generate cash flow in the future. If the Company is unable to generate sufficient cash flow or otherwise obtain funds necessary to make required payments, or if the Company fails to comply with the various requirements of the Notes, the Company would be in default, which would permit the holders of the Notes to accelerate the maturity of the Notes and cause a default under the Notes. Any default under the Notes could have a material adverse effect on the Company’s business, results of operations and financial condition. (f) The Company may choose to raise additional funds in connection with any potential acquisition of patent portfolios or other intellectual property assets or operating businesses. In addition, the Company may also need additional funds to respond to business opportunities and challenges, including its ongoing operating expenses, protection of its assets, development of new lines of business and enhancement of its operating infrastructure. While the Company may need to seek additional funding, it may not be able to obtain financing on acceptable terms, or at all. If the Company is unable to obtain additional funding on a timely basis, it may be required to curtail or terminate some of its business plans.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2015
Subsequent Events [Abstract]
Subsequent Events	Note 12. Subsequent Events On October 15, 2015, the Company completed the acquisition of International Development Group Limited, a Maryland corporation (“IDG”). Pursuant to the Stock Purchase Agreement (“the Purchase Agreement”), the Company acquired 100 70 In consideration for the acquisition, the Company issued an aggregate of 1,609,167 0.01 1,604,167 5,000 240,625 1,609,167 16,091,670 575,000 In connection with the acquisition, the Company also entered into a Consulting Agreement with IDG’s former Chief Executive Officer and director for an initial term of six months, which may be extended on a month-to-month basis or longer thereafter, and the payment of $ 9,000 In connection with the entry into the Purchase Agreement, the Company issued to a finder a warrant to purchase up to an aggregate of 500,000 0.50 April 15, 2021 .

Accounting and Reporting Poli19

Accounting and Reporting Policies (Policies)	9 Months Ended
	Sep. 30, 2015
Accounting Policies [Abstract]
Basis of presentation and principles of consolidation	(a) Basis of presentation and principles of consolidation The accompanying interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information and the instructions to Rule 10-01 of Regulation S-X, and should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2014. All adjustments that, in the opinion of management, are necessary for a fair presentation for the periods presented have been reflected by the Company. Such adjustments are of a normal, recurring nature. The results of operations for the three month and nine month periods ended September 30, 2015 are not necessarily indicative of the results that may be expected for the entire fiscal year or for any other interim period. All significant intercompany balances and transactions have been eliminated in consolidation.
Use of estimates	(b) Use of estimates The preparation of accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from such estimates. Significant items subject to such estimates and assumptions include the Company’s intangibles assets, the useful lives of the Company’s intangible assets, the valuation of the Company’s derivative warrants, the valuation of stock-based compensation, deferred tax assets and liabilities, income tax uncertainties, and other contingencies.
Translation into U.S. dollars	(c) Translation into U.S. dollars The Company conducts certain transactions in foreign currencies, which are recorded at the exchange rate as of the transaction date. All exchange gains and losses occurring from the remeasurement of monetary balance sheet items denominated in non-U.S. dollar currencies are reflected as non-operating income or expense in the consolidated statements of operations.
Cash and cash equivalents	(d) Cash and cash equivalents The Company invests its cash in money market funds with financial institutions. The Company has established guidelines relating to diversification and maturities of its investments in order to minimize credit risk and maintain high liquidity of funds. All highly liquid investments with original maturities of three months or less at acquisition date are considered cash equivalents.
Derivative instruments	(e) Derivative instruments The Company recognizes all derivative instruments as either assets or liabilities in the consolidated balance sheets at their respective fair values. The Company's derivative instruments have been recorded as liabilities at fair value, and are revalued at each reporting date, with changes in the fair value of the instruments included in the consolidated statements of operations as non-operating income (expense). The Company reviews the terms of features embedded in non-derivative instruments to determine if such features require bifurcation and separate accounting as derivative financial instruments. Equity-linked derivative instruments are evaluated in accordance with FASB Accounting Standard Codification 815-40, Contracts in an Entity’s Own Equity
Intangible assets	(f) Intangible assets Intangible assets include purchased patents which are recorded based on the cost to acquire them. These assets are amortized over their remaining estimated useful lives, which are periodically evaluated for reasonableness. The Company’s intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In assessing the recoverability of the Company's intangible assets, the Company must make estimates and assumptions regarding future cash flows and other factors to determine the fair value of the respective assets. These estimates and assumptions could have a significant impact on whether an impairment charge is recognized and also the magnitude of any such charge. Fair value estimates are made at a specific point in time, based on relevant information. These estimates are subjective in nature and involve uncertainties and matters of significant judgments and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates. If these estimates or material related assumptions change in the future, the Company may be required to record impairment charges related to its intangible assets.
Revenue recognition	(g) Revenue recognition Revenue from patent licensing and enforcement is recognized if collectability is reasonably assured, persuasive evidence of an arrangement exists, the sales price is fixed or determinable and delivery of the service has been rendered. The Company uses management's best estimate of selling price for individual elements in multiple-element arrangements, where vendor specific evidence or third party evidence of selling price is not available. Currently, the Company’s revenue arrangements provide for the payment of contractually determined fees and other consideration for the grant of certain intellectual property rights related to the Company’s patents. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patents, (ii) the release of the licensee from certain claims, and (iii) the dismissal of any pending litigation. The intellectual property rights granted typically extend until the expiration of the related patents. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on the Company’s part to maintain or upgrade the related technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the upfront payment. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, upon receipt of the upfront fee, and when all other revenue recognition criteria have been met.
Operating legal costs	(h) Operating legal costs Operating legal costs mainly include expenses incurred in connection with the Company’s patent licensing and enforcement activities, patent-related legal expenses paid to external patent counsel (including contingent legal fees), licensing and enforcement related research, consulting and other expenses paid to third parties, as well as related internal payroll expenses and stock-based compensation. In addition, amounts received by the Company for reimbursements of legal fees in connection with its litigation campaigns are recorded in Operating legal costs as an offset to legal expense.
Stock-based compensation	(i) Stock-based compensation Stock-based compensation is recognized as an expense in the consolidated statements of operations and such cost is measured at the grant-date fair value of the equity-settled award. The fair value of stock options is estimated at the date of grant using the Black-Scholes-Merton option-pricing model. The expense is recognized on a straight-line basis, over the requisite service period. The Company uses the simplified method to estimate the expected term of options due to insufficient history and high turnover in the past. Since the Company lacks sufficient history, expected volatility is estimated based on a weighted average historical volatility of the Company and comparable entities with publicly traded shares. The risk-free rate for the expected term of the option is based on the U.S. Treasury yield curve at the date of grant.
Recently Issued Accounting Pronouncements	(j) Recently Issued Accounting Pronouncements In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements (Topic 205): Going Concern In November 2014, the FASB issued ASU 2014-16, Derivatives and Hedging: Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share is More Akin to Debt or to Equity In April 2015, the FASB issued ASU No. 2015-03, Simplifying the Presentation of Debt Issuance Costs
Reclassification	(k) Reclassification Certain balances have been reclassified to conform to presentation requirements.

Intangible Assets (Tables)

Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Components of Finite-Lived Intangible Assets	The following table provides information regarding the Company’s intangible assets, which consist of its patents: September 30, December 31, Weighted average 2015 2014 amortization period (years) Patents $ 28,213 $ 28,213 8.9 Less: accumulated amortization and impairment (13,024) (10,588) $ 15,189 $ 17,625

Net Loss per Common Share (Tabl

Net Loss per Common Share (Tables)	9 Months Ended
	Sep. 30, 2015
Earnings Per Share, Basic and Diluted [Abstract]
Computation of Net Loss per Common Share	Three months ended Nine months ended September 30, September 30, 2015 2014 2015 2014 Basic Numerator: Loss from continuing operations attributable to shares of common stock $ (11,871) $ (12,376) $ (27,356) $ (33,325) Loss from discontinued operations attributable to shares of common stock — — $ — $ (209) Net loss attributable to shares of common stock $ (11,871) $ (12,376) $ (27,356) $ (33,534) Basic Denominator: Weighted average number of shares of common stock outstanding during the period 102,466,238 92,624,983 96,887,444 88,463,526 Basic common stock shares outstanding 102,466,238 92,624,983 96,887,444 88,463,526 Basic loss per common stock share from continuing operations $ (0.12) $ (0.13) $ (0.28) $ (0.38) Basic loss per common stock share from discontinued operations (0.00) (0.00) (0.00) (0.00) Basic net loss per common stock share $ (0.12) $ (0.13) $ (0.28) $ (0.38) Diluted Numerator: Net loss from continuing operations attributable to shares of common stock $ (11,871) $ (12,376) $ (27,356) $ (33,325) Increase in net loss attributable to derivative warrants — (2,785) — (2,057) Diluted net loss from continuing operations attributable to shares of common stock (11,871) (15,161) (27,356) (35,382) Diluted net loss from discontinued operations attributable to shares of common stock — — — (209) Diluted net loss attributable to shares of common stock $ (11,871) $ (15,161) $ (27,356) $ (35,591) Diluted Denominator: Basic common stock shares outstanding 102,466,238 92,624,983 96,887,444 88,463,526 Weighted average number of derivative warrants outstanding during the period — 20,316 — 1,051,326 Diluted common stock shares outstanding 102,466,238 92,645,299 96,887,444 89,514,852 Diluted loss per common stock share from continuing operations $ (0.12) $ (0.16) $ (0.28) $ (0.40) Diluted loss per common stock share from discontinued operations (0.00) (0.00) (0.00) (0.00) Diluted net loss per common stock share $ (0.12) $ (0.16) $ (0.28) $ (0.40) Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact: Both vested and unvested options to purchase an equal number of shares of common stock of the Company 8,714,845 10,089,595 8,714,845 10,089,595 Unvested RSUs to issue an equal number of shares of common stock of the Company 543,231 1,425,872 543,231 1,425,872 Warrants to purchase an equal number of shares of common stock of the Company 9,566,796 17,388,161 9,566,796 16,147,560 Conversion feature of Senior Secured Notes 11,309,524 — 12,500,000 — Total number of potentially dilutive instruments, excluded from the calculation of net loss per share 30,134,396 28,903,628 31,324,872 27,663,027

Discontinued Operations (Tables

Discontinued Operations (Tables)	9 Months Ended
	Sep. 30, 2015
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures	The following table represents the components of operating results from discontinued operations for the nine month period ended September 30, 2014, as presented in the consolidated statements of operations: Revenue $ 37 Operating expenses (266) Operating loss (229) Non-operating income 20 Loss before taxes on income (209) Income tax expense - Loss from discontinued operations $ (209)

Senior Secured Convertible No23

Senior Secured Convertible Notes (Tables)	9 Months Ended
	Sep. 30, 2015
Debt Disclosure [Abstract]
Schedule of Debt	Upon issuance of the Notes on May 4, 2015, the Company recorded the following as of June 30, 2015 and September 30, 2015: Net cash proceeds from the Notes ($12,500 less investors issuance costs of $75) $ 12,425 Debt discount: May 2015 Warrants 1,717 Conversion feature 1,244 Total Debt discount attributed to Warrants and Conversion feature 2,961 Net Total – May 4, 2015 9,464 Q2 Debt discount amortization 289 Q2 Debt repayments (1,191) Net Total – June 30, 2015 8,562 Q3 Debt discount amortization 1,436 Q3 Debt repayments (5,912) Net Total – September 30, 2015 (presented as short-term) $ 4,086

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2015
Fair Value Measurements [Abstract]
Assets and Liabilities Measured at Fair Value on Recurring Basis	The following table presents the placement in the fair value hierarchy of liabilities measured at fair value on a recurring basis as of September 30, 2015 and December 31, 2014: Fair value measurement at reporting date using Quoted prices in active markets Significant other Significant for identical observable unobservable Balance assets (Level 1) inputs (Level 2) inputs (Level 3) September 30, 2015: May 2015 Warrants $ 1,475 $ — $ — $ 1,475 Conversion feature $ 75 $ — $ — $ 75 December 31, 2014: Conversion Warrants, the derivative Reload Warrants and the derivative Series 1 Warrants $ 175 $ — $ — $ 175
Changes in Liabilities Measured at Fair Value Using Significant Unobservable Inputs	Conversion Warrants, the derivative Reload Warrants and the derivative May 2015 Conversion Series 1 Warrants Warrants feature December 31, 2014 $ 175 $ — $ — Reclassification of derivative Reload Warrants and Series 1 Warrants to equity warrants (175) — — Issuance of Notes and derivative warrants on May 4, 2015 — 1,717 1,244 Gain on revaluation of warrants and conversion feature — (242) (1,169) September 30, 2015 — 1,475 75
Fair Value Measurements Based Upon Sensitivity and Nature of Inputs	Fair value measurement of the derivative warrant liabilities falls within Level 3 of the fair value hierarchy. The fair value measurements are evaluated by management to ensure that changes are consistent with expectations of management based upon the sensitivity and nature of the inputs. December 31, 2014: Unobservable Description Valuation technique inputs Range Conversion Warrants, derivative Reload Warrants and derivative Series 1 Warrants Black-Scholes-Merton and the Monte-Carlo models Volatility 56.55 77.06 Risk free interest rate 0.13 0.87 Expected term, in years 0.48 2.55 Dividend yield 0 September 30, 2015: Unobservable Description Valuation technique inputs Range Conversion feature Monte-Carlo model Volatility 65.82 Risk free interest rate 0.13 Expected term, in years 0.76 Conversion price $ 1.00 May 2015 Warrants Black-Scholes-Merton Volatility 78.18 Risk free interest rate 1.30 Expected term, in years 4.59 Dividend yield 0.00

Warrants (Tables)

Warrants (Tables)	9 Months Ended
	Sep. 30, 2015
Warrants and Rights Note Disclosure [Abstract]
Schedule Of Changes In Warrants Activity	The following table summarizes information about warrant activity during the nine month period ended September 30, 2015: Weighted average Exercise No. of warrants exercise price price range December 31, 2014 17,402,654 $ 4.26 $0.94 - $5.06 Granted 5,375,000 $ 1.00 $1.00 Exercised — — — Expired (13,210,858) $ 5.06 $0.94 - $5.06 September 30, 2015 9,566,796 $ 1.33 $1.00 - $1.76
Schedule Of Warrants Outstanding	The Company’s outstanding equity warrants as of September 30, 2015 consist of the following: Remaining No. outstanding Exercise price contractual life Expiration Date Series 1 Warrants 1,490,250 $ 1.76 1.80 years July 19, 2017 Series 2 Warrants 1,943,523 $ 1.76 1.80 years July 19, 2017 Reload Warrants 758,023 $ 1.76 1.36 years February 6, 2017 Outstanding as of September 30, 2015 4,191,796 The Company’s outstanding derivative liability warrants as of September 30, 2015 consist of the following: Remaining No. outstanding Exercise price contractual life Expiration Date May 2015 Warrants 5,375,000 $ 1.00 4.59 years May 4, 2020

Stock-based Compensation (Table

Stock-based Compensation (Tables)	9 Months Ended
	Sep. 30, 2015
Share-based Compensation [Abstract]
Schedule of Options Granted	The following table illustrates the stock options granted during the nine month period ended September 30, 2015: No. of Fair market value Assumptions used in Black-Scholes Title Grant date options Exercise price at grant date Vesting terms Option pricing model Directors and employees January 2015 1,150,000 $0.51 - $0.59 $0.33 - $0.38 Over 1 year for Directors; Over 3 years for Volatility: 74.9 % - 77.1 Employees Risk free interest rate: 1.27 1.51 Expected term, in years: 5.31 5.81 Dividend yield: 0.00
Stock Options and Restricted Stock Units Activity	The activity related to stock options and RSUs during the nine month period ended September 30, 2015 consisted of the following: RSUs Options Weighted average Weighted average Weighted average No. of RSUs grant date fair value No. of options exercise price Exercise price range grant date fair value Outstanding at December 31, 2014 1,196,357 $ 3.64 8,052,345 $ 3.36 $0.96 - $5.50 $ 2.24 Granted — — 1,150,000 $ 0.54 $0.51 - $0.59 $ 0.35 Vested/Exercised (299,480) $ 3.65 — — — — Forfeited (353,646) $ 3.63 (487,500) $ 1.94 $0.51 - $3.76 $ 1.11 Expired — — — — — — Outstanding at September 30, 2015 543,231 $ 3.63 8,714,845 $ 3.07 $0.51 - $5.50 $ 2.05 Exercisable at September 30, 2015 — — 7,787,485 $ 3.20 $0.51 - $5.50

General (Additional Information

General (Additional Information) (Details) - USD ($) $ / shares in Units, $ in Thousands	May. 04, 2015	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014	Feb. 18, 2014	Dec. 31, 2013
Cost Method Investment Ownership Percentage					8.25%
Cash		$ 14,402
Average Monthly Cash Spent In Operations		1,500	$ 2,200
Proceeds from Issuance of Warrants	$ 12,425
Stockholders Equity		16,702	$ 104,919	$ 31,180		$ 114,282
Deposits Assets, Current		$ 1,970		$ 2,067
Debt Discount Percentage		15.00%
Notes Payable, Other Payables [Member]
Debt Instrument, Maturity Date, Description		July 2,016
International Development Group Limited [Member]
Equity Method Investment, Ownership Percentage		100.00%
fliCharge International Ltd [Member]
Equity Method Investment, Ownership Percentage		70.00%
Pending Litigation [Member]
Deposits Assets, Current		$ 1,970
Warrant [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1
Warrants Issued During Period Shares	5,375,000
Senior Notes [Member]
Debt Discount Percentage	15.00%
Debt Instrument, Face Amount	$ 12,500
Debt Instrument, Convertible, Conversion Price	$ 1
Debt Instrument, Interest Rate, Stated Percentage	8.00%
Debt Instrument, Term	21 months

Intangible Assets (Additional I

Intangible Assets (Additional Information) (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
	Aug. 31, 2012	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Finite-Lived Intangible Assets [Line Items]
Impairment of Intangible Assets, Finite-lived			$ 1,355
Capitalize Cost Related To Acquisition Of Patents	$ 548
Royalty Payable On Excess Of Acquisition Cost	35.00%
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization of Intangible Assets		$ 819	$ 978	$ 2,436	$ 2,903
Payments to Acquire Intangible Assets	$ 22,000

Intangible Assets (Schedule of

Intangible Assets (Schedule of Finite-Lived Intangible Assets) (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Patents	$ 28,213	$ 28,213
Less: accumulated amortization and impairment	(13,024)	(10,588)
Finite-Lived Intangible Assets, Net	$ 15,189	$ 17,625
Weighted average amortization period (years)	8 years 10 months 24 days

Net Loss per Common Share (Comp

Net Loss per Common Share (Computation of basic and diluted net losses per common share) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Earnings Per Share Disclosure [Line Items]
Loss from continuing operations attributable to shares of common stock	$ (11,871)	$ (12,376)	$ (27,356)	$ (33,325)
Loss from discontinued operations attributable to shares of common stock	0	0	0	(209)
Net loss attributable to shares of common stock	$ (11,871)	$ (12,376)	$ (27,356)	$ (33,534)
Basic common stock shares outstanding	102,466,238	92,624,983	96,887,444	88,463,526
Basic loss per common stock share from continuing operations	$ (0.12)	$ (0.13)	$ (0.28)	$ (0.38)
Basic loss per common stock share from discontinued operations	0	0	0	0
Basic net loss per common stock share	$ (0.12)	$ (0.13)	$ (0.28)	$ (0.38)
Diluted common stock shares outstanding	102,466,238	92,645,299	96,887,444	89,514,852
Diluted loss per common stock share from continuing operations	$ (0.12)	$ (0.16)	$ (0.28)	$ (0.4)
Diluted loss per common stock share from discontinued operations	0	0	0	0
Diluted net loss per common stock share	$ (0.12)	$ (0.16)	$ (0.28)	$ (0.4)
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	30,134,396	28,903,628	31,324,872	27,663,027
Basic Numerator [Member]
Earnings Per Share Disclosure [Line Items]
Loss from continuing operations attributable to shares of common stock	$ (11,871)	$ (12,376)	$ (27,356)	$ (33,325)
Loss from discontinued operations attributable to shares of common stock	0	0	0	(209)
Net loss attributable to shares of common stock	$ (11,871)	$ (12,376)	$ (27,356)	$ (33,534)
Basic Denominator [Member]
Earnings Per Share Disclosure [Line Items]
Weighted average number of shares of common stock outstanding during the period	102,466,238	92,624,983	96,887,444	88,463,526
Basic common stock shares outstanding	102,466,238	92,624,983	96,887,444	88,463,526
Basic loss per common stock share from continuing operations	$ (0.12)	$ (0.13)	$ (0.28)	$ (0.38)
Basic loss per common stock share from discontinued operations	0	0	0	0
Basic net loss per common stock share	$ (0.12)	$ (0.13)	$ (0.28)	$ (0.38)
Diluted Numerator [Member]
Earnings Per Share Disclosure [Line Items]
Loss from continuing operations attributable to shares of common stock	$ (11,871)	$ (12,376)	$ (27,356)	$ (33,325)
Increase in net loss attributable to derivative warrants	0	(2,785)	0	(2,057)
Diluted net loss from continuing operations attributable to shares of common stock	(11,871)	(15,161)	(27,356)	(35,382)
Diluted net loss from discontinued operations attributable to shares of common stock	0	0	0	(209)
Diluted net loss attributable to shares of common stock	$ (11,871)	$ (15,161)	$ (27,356)	$ (35,591)
Diluted Denominator [Member]
Earnings Per Share Disclosure [Line Items]
Basic common stock shares outstanding	102,466,238	92,624,983	96,887,444	88,463,526
Shares assumed issued upon exercise of derivative warrants during the period	0	20,316	0	1,051,326
Diluted common stock shares outstanding	102,466,238	92,645,299	96,887,444	89,514,852
Diluted loss per common stock share from continuing operations	$ (0.12)	$ (0.16)	$ (0.28)	$ (0.4)
Diluted loss per common stock share from discontinued operations	0	0	0	0
Diluted net loss per common stock share	$ (0.12)	$ (0.16)	$ (0.28)	$ (0.4)
Both vested and unvested options to purchase an equal number of shares of common stock of the Company
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	8,714,845	10,089,595	8,714,845	10,089,595
Unvested Restricted Stock Units (“RSU”) [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	543,231	1,425,872	543,231	1,425,872
Warrants to purchase an equal number of shares of common stock of the Company [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	9,566,796	17,388,161	9,566,796	16,147,560
Conversion feature of Senior Secured Notes [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	11,309,524	0	12,500,000	0

Discontinued Operations (Additi

Discontinued Operations (Additional Information) (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014	Feb. 18, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cost Method Investment Ownership Percentage			8.25%
Infomedia [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cost Method Investment Ownership Percentage			8.25%
Cost Method Investments	$ 787	$ 787

Discontinued Operations (Dispos

Discontinued Operations (Disposal Group Not Discontinued Operation Income Statement Disclosures) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue				$ 37
Operating expenses				(266)
Operating loss				(229)
Non-operating income				20
Loss before taxes on income				(209)
Income tax expense	$ 0	$ 0	$ 0	0
Loss from discontinued operations	$ 0	$ 0	$ 0	$ (209)

Senior Secured Convertible No33

Senior Secured Convertible Notes (Additional Information) (Details) - USD ($) $ / shares in Units, $ in Thousands	May. 04, 2015	Sep. 30, 2015	Sep. 30, 2014	Jun. 30, 2015	Sep. 30, 2015	Sep. 30, 2014
Proceeds From Issuance Of Notes Payable And Warrants					$ 12,425	$ 0
Payments of Debt Issuance Costs					218	0
Debt Instrument, Periodic Payment, Principal		$ 5,912			$ 7,103
Debt Discount Percentage					15.00%
Debt Instrument, Description					Notes contain provisions that under certain events of default, as defined in the agreement, the amount owed could increase by amounts ranging from 115% to 120% of the face value depending on when the event occurred, and additionally, the interest rates would increase to 16.5% per annum upon the occurrence and continuance of an event of default. In addition, the Company may choose to repay the Notes early at a premium ranging from 115% to 120% of the face value depending on when the election is made.
Amortization of Debt Discount (Premium)		1,436		$ 289	$ 1,725	0
Amortization of Financing Costs		93			114	0
Accounts Payable and Accrued Liabilities		179			179
Extinguishment of Debt, Amount		$ 1,044	$ 0		$ 1,254	$ 0
Stock Issued During Period, Shares, New Issues		14,600,000			16,900,000
Warrant [Member]
Warrants Issued During Period Shares	5,375,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1
Senior Note [Member]
Debt Instrument, Face Amount	$ 12,500
Debt Instrument, Convertible, Conversion Price	$ 1
Debt Instrument, Interest Rate, Stated Percentage	8.00%
Debt Instrument, Term	21 months
Debt Instrument, Periodic Payment, Principal					$ 595

Senior Secured Convertible No34

Senior Secured Convertible Notes (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended	9 Months Ended
	Sep. 30, 2015	Jun. 30, 2015	Sep. 30, 2015	Sep. 30, 2014	May. 04, 2015
Net cash proceeds from the Notes ($12,500 less investors issuance costs of $75)			$ 12,425	$ 0
Debt Instrument, Unamortized Discount					$ 2,961
Convertible Notes Payable	$ 4,086	$ 8,562	4,086		9,464
Debt discount amortization	1,436	289	$ 1,725	$ 0
Debt repayments	$ (5,912)	$ (1,191)
May Twenty Fifteen Warrants [Member]
Debt Instrument, Unamortized Discount					1,717
Conversion Warrants [Member]
Debt Instrument, Unamortized Discount					$ 1,244

Fair Value Measurements (Additi

Fair Value Measurements (Additional Information) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Sep. 30, 2015
Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity	$ 175
Derivative Liabilities Noncurrent	174	$ 1,475
Derivative Liability, Current	$ 1

Fair Value Measurements (Assets

Fair Value Measurements (Assets and Liabilities Measured at Fair Value on Recurring Basis) (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Liabilities
Derivative liabilities	$ 75	$ 175
Warrant [Member]
Liabilities
Derivative liabilities	1,475
Fair Value, Inputs, Level 1 [Member]
Liabilities
Derivative liabilities	0	0
Fair Value, Inputs, Level 1 [Member] | Warrant [Member]
Liabilities
Derivative liabilities	0
Fair Value, Inputs, Level 2 [Member]
Liabilities
Derivative liabilities	0	0
Fair Value, Inputs, Level 2 [Member] | Warrant [Member]
Liabilities
Derivative liabilities	0
Fair Value Inputs Level 3 [Member]
Liabilities
Derivative liabilities	75	$ 175
Fair Value Inputs Level 3 [Member] | Warrant [Member]
Liabilities
Derivative liabilities	$ 1,475

Fair Value Measurements (Change

Fair Value Measurements (Changes In Company's Liabilities Measured At Fair Value Using Significant Unobservable Inputs) (Details) - USD ($) $ in Thousands	May. 04, 2015	Sep. 30, 2015
December 31, 2014		$ 175
Issuance of Notes and derivative warrants on May 4, 2015	$ 12,425
September 30, 2015		75
Series One Warrants [Member]
December 31, 2014		175
Reclassification of derivative Reload Warrants and Series 1 Warrants to equity warrants		(175)
Issuance of Notes and derivative warrants on May 4, 2015		0
Gain on revaluation of warrants and conversion feature		0
September 30, 2015		0
May Twenty Fifteen Warrants [Member]
December 31, 2014		0
Reclassification of derivative Reload Warrants and Series 1 Warrants to equity warrants		0
Issuance of Notes and derivative warrants on May 4, 2015		1,717
Gain on revaluation of warrants and conversion feature		(242)
September 30, 2015		1,475
Conversion Warrants [Member]
December 31, 2014		0
Reclassification of derivative Reload Warrants and Series 1 Warrants to equity warrants		0
Issuance of Notes and derivative warrants on May 4, 2015		1,244
Gain on revaluation of warrants and conversion feature		(1,169)
September 30, 2015		$ 75

Fair Value Measurements (Based

Fair Value Measurements (Based Upon Sensitivity and Nature of Inputs) (Details) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Dividend yield		0.00%
May 2015 Warrants [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Volatility	78.18%
Risk free interest rate	1.30%
Expected term, in years	4 years 7 months 2 days
Dividend yield	0.00%
Conversion feature [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Volatility	65.82%
Risk free interest rate	0.13%
Expected term, in years	9 months 4 days
Conversion Price	$ 1
Minimum [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Volatility		56.55%
Risk free interest rate		0.13%
Expected term, in years		5 months 23 days
Maximum [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Volatility		77.06%
Risk free interest rate		0.87%
Expected term, in years		2 years 6 months 18 days

Warrants (Additional Informatio

Warrants (Additional Information) (Details) - $ / shares	May. 04, 2015	Jun. 21, 2015
Warrant [Member]
Exercise Price	$ 1
Warrants Issued	5,375,000
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable In Period	5 years
IPO [Member]
Exercise Price		$ 5.06
Warrant outstanding		4,784,000
Private [Member]
Warrant outstanding		8,426,858
Warrants Expired		Jun. 21, 2015

Warrants (Schedule Of Changes I

Warrants (Schedule Of Changes In Warrants Activity) (Details) - Warrant [Member]	9 Months Ended
	Sep. 30, 2015$ / sharesshares
Beginning Balance | shares	17,402,654
Granted | shares	5,375,000
Exercised | shares	0
Expired | shares	(13,210,858)
Ending Balance | shares	9,566,796
Outstanding at January 1, 2015, Weighted average exercise price	$ 4.26
Granted, Weighted average exercise price	1
Exercised, Weighted average exercise price	0
Expired, Weighted average exercise price	5.06
Outstanding at September 30, 2015, Weighted average exercise price	1.33
Granted, Exercise price range	1
Exercised, Exercise price range	0
Maximum [Member]
Outstanding at January 1, 2015, Exercise price range	5.06
Expired, Exercise price range	5.06
Outstanding at September 30, 2015, Exercise price range	1.76
Minimum [Member]
Outstanding at January 1, 2015, Exercise price range	0.94
Expired, Exercise price range	0.94
Outstanding at September 30, 2015, Exercise price range	$ 1

Warrants (Schedule of Warrants

Warrants (Schedule of Warrants Outstanding) (Details)	9 Months Ended
	Sep. 30, 2015$ / sharesshares
No. outstanding	4,191,796
Series 1 Warrants [Member]
No. outstanding	1,490,250
Exercise price | $ / shares	$ 1.76
Remaining contractual life	1 year 9 months 18 days
Expiration Date	July 19, 2017
Series 2 Warrants [Member]
No. outstanding	1,943,523
Exercise price | $ / shares	$ 1.76
Remaining contractual life	1 year 9 months 18 days
Expiration Date	July 19, 2017
Reload Warrants [Member]
No. outstanding	758,023
Exercise price | $ / shares	$ 1.76
Remaining contractual life	1 year 4 months 10 days
Expiration Date	February 6, 2017
May Twenty Fifteen Warrants [Member]
No. outstanding	5,375,000
Exercise price | $ / shares	$ 1
Remaining contractual life	4 years 7 months 2 days
Expiration Date	May 4, 2020

Stock-based Compensation (Addit

Stock-based Compensation (Additional Information) (Details)	9 Months Ended
	Sep. 30, 2015shares
Maximum [Member]
Stockholders Equity [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	100.00%
Minimum [Member]
Stockholders Equity [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	75.00%
Two Thousand Twelve Stock Option Plan [Member]
Stockholders Equity [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	5,462,066
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	15,600,000

Stock-based Compensation (Sched

Stock-based Compensation (Schedule Of Common Stock Options Granted) (Details) - $ / shares	9 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Stockholders Equity [Line Items]
No. of options	1,150,000
Exercise price	$ 3.07	$ 3.36
Fair market value at grant date	0.35
Maximum [Member]
Stockholders Equity [Line Items]
Exercise price	5.50	5.50
Minimum [Member]
Stockholders Equity [Line Items]
Exercise price	$ 0.51	$ 0.96
Management Directors and Employees [Member]
Stockholders Equity [Line Items]
Grant Date	January 2,015
No. of options	1,150,000
Vesting terms	Over 1 year for Directors; Over 3 years for Employees
Volatility Rate, Minimum	74.90%
Volatility Rate, Maximum	77.10%
Risk free interest rate, Minimum	1.27%
Risk free interest rate, Maximum	1.51%
Dividend yield	0.00%
Management Directors and Employees [Member] | Maximum [Member]
Stockholders Equity [Line Items]
Exercise price	$ 0.59
Fair market value at grant date	$ 0.38
Expected term, in years	5 years 9 months 22 days
Management Directors and Employees [Member] | Minimum [Member]
Stockholders Equity [Line Items]
Exercise price	$ 0.51
Fair market value at grant date	$ 0.33
Expected term, in years	5 years 3 months 22 days

Stock-based Compensation (Stock

Stock-based Compensation (Stock options and RSU activity) (Details)	9 Months Ended
	Sep. 30, 2015$ / sharesshares
Stockholders Equity [Line Items]
No. of options, Outstanding at January 1, 2015 | shares	8,052,345
No. of options, Granted | shares	1,150,000
No. of options, Vested/Exercised | shares	0
No. of options, Forfeited | shares	(487,500)
No. of options, Expired | shares	0
No. of options, Outstanding at September 30, 2015 | shares	8,714,845
No. of options, Exercisable at September 30, 2015 | shares	7,787,485
Exercise price range, Outstanding at January 1, 2015	$ 3.36
Exercise price range, Granted	0.54
Exercise price range, Vested/Exercised	0
Exercise price range, Forfeited	1.94
Exercise price range, Expired	0
Exercise price range, Outstanding September 30, 2015	3.07
Exercise price range, Exercisable at September 30, 2015	3.2
Weighted average grant date fair value, Outstanding at January 1, 2015	2.24
Weighted average grant date fair value, Granted	0.35
Weighted average grant date fair value, Vested/Exercised	0
Weighted average grant date fair value, Forfeited	1.11
Weighted average grant date fair value, Expired	0
Weighted average grant date fair value, Outstanding at September 30, 2015	2.05
Restricted Stock [Member]
Stockholders Equity [Line Items]
Weighted average grant date fair value, Outstanding at January 1, 2015	3.64
Weighted average grant date fair value, Outstanding at September 30, 2015	$ 3.63
Beginning Balance | shares	1,196,357
No. of RSUs, Granted | shares	0
No. of RSUs, Vested/Exercised | shares	(299,480)
No. of RSUs, Forfeited | shares	(353,646)
No. of RSUs, Expired | shares	0
Ending Balance | shares	543,231
No. of RSUs, Exercisable at September 30, 2015 | shares	0
Weighted average grant date fair value, Granted	$ 0
Weighted average grant date fair value, Vested/Exercised	3.65
Weighted average grant date fair value, Forfeited	3.63
Weighted average grant date fair value, Expired	0
Weighted average grant date fair value, Exercisable at September 30, 2015	0
Minimum [Member]
Stockholders Equity [Line Items]
Exercise price range, Outstanding at January 1, 2015	0.96
Exercise price range, Granted	0.51
Exercise price range, Forfeited	0.51
Exercise price range, Outstanding September 30, 2015	0.51
Exercise price range, Exercisable at September 30, 2015	0.51
Maximum [Member]
Stockholders Equity [Line Items]
Exercise price range, Outstanding at January 1, 2015	5.50
Exercise price range, Granted	0.59
Exercise price range, Forfeited	3.76
Exercise price range, Outstanding September 30, 2015	5.50
Exercise price range, Exercisable at September 30, 2015	$ 5.50

Commitments and Contingencies (

Commitments and Contingencies (Additional Information) (Details) € in Thousands, BRL in Thousands, $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2015USD ($)	Sep. 30, 2014USD ($)	Sep. 30, 2015USD ($)	Sep. 30, 2014USD ($)	Dec. 31, 2014USD ($)	May. 20, 2015EUR (€)	Feb. 11, 2015EUR (€)	May. 05, 2014EUR (€)	Apr. 17, 2014BRL	Nov. 30, 2012USD ($)
Loss Contingencies [Line Items]
Rental expense for operating leases	$ 91	$ 91	$ 274	$ 273
Deposits Assets, Current	1,970		1,970		$ 2,067
ZTE In Germany [Member]
Loss Contingencies [Line Items]
Deposits Assets, Current	1,124		1,124					€ 1,000
ZTE In Romania [Member]
Loss Contingencies [Line Items]
Deposits Assets, Current	273		273				€ 243
ZTE In Brazil [Member]
Loss Contingencies [Line Items]
Deposits Assets, Current	492		492						BRL 2,020
Enforce [Member]
Loss Contingencies [Line Items]
Deposits Assets, Current	$ 56		$ 56			€ 50
Until Renovation Of Building [Member]
Loss Contingencies [Line Items]
Operating Lease Rent Expense Annual Fee					$ 403
Maximum [Member] | Written Commitment One [Member]
Loss Contingencies [Line Items]
Guarantee placed for contingent loss in litigation										$ 2,900

Subsequent Events (Additional I

Subsequent Events (Additional Information) (Details) - Subsequent Event [Member] $ / shares in Units, $ in Thousands	Oct. 15, 2015USD ($)$ / sharesshares
Subsequent Event [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired	100.00%
Sale of Stock, Percentage of Ownership before Transaction	70.00%
Chief Executive Officer [Member]
Subsequent Event [Line Items]
Deferred Compensation Arrangement with Individual, Compensation Expense | $	$ 9,000
Common Stock [Member]
Subsequent Event [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	$ 0.50
Class of Warrant or Right, Date from which Warrants or Rights Exercisable	Apr. 15, 2021
Unregistered Common Stock Issued For Forgiveness Of Debt	575,000
International Development Group Limited [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion	16,091,670
International Development Group Limited [Member] | Series B Preferred Stock [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, Acquisitions	1,609,167
Preferred Stock, Par Or Stated Value Per Share | $ / shares	$ 0.01
Preferred Stock, Capital Shares Reserved for Future Issuance	240,625
Conversion of Stock, Shares Converted	1,609,167
Shareholders [Member] | Series B Preferred Stock [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, Acquisitions	1,604,167
Legal Counsel [Member] | Series B Preferred Stock [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, Acquisitions	5,000